Market revenue in 2023 | USD 0.8 million |
Market revenue in 2030 | USD 2.9 million |
Growth rate | 19.6% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Neurology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the India 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
India's 3D printed drugs market is witnessing notable growth, driven by several factors fostering a conducive environment for innovation & development. One significant driver is the growing focus on R&D in 3D printed drugs, with increased investment in cutting-edge technologies & methodologies.
Furthermore, India's rapidly aging population and the increasing prevalence of chronic diseases have created a pressing need for cutting-edge medical technologies such as 3D printing, which is expected to support the production of personalized medicine.
Furthermore, the government's initiatives to promote innovation, research, and technology adoption in the healthcare sector, along with a thriving startup ecosystem, are propelling the growth of 3D printed drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the India 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into India 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account